在严重喘中使用葡萄糖皮质激素治疗
María Florencia Pilia1,2,3, David Espejo-Castellanos1,2,3, Christian Romero-Mesones1,2,3
1Servei de Pneumologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Seminars in respiratory and critical care medicine
|November 14, 2025
概括
严重喘治疗面临的挑战是长期的葡萄糖皮质激素 (GC) 毒性. 生物疗法提供了一个有希望的替代方案,显著减少GC的依赖和改善患者在类固醇依赖喘的结果.
科学领域:
- 肺病学和呼吸系统医学
- 临床药理学 临床药理学
- 免疫学 免疫学 免疫学
背景情况:
- 严重的喘影响3-10%的喘患者,通常需要高强度治疗.
- 葡萄糖皮质类药物 (GCs) 是标准的,但与毒性和基于炎症内型 (T2与非T2) 的可变反应有关.
- GC抵抗机制包括GRβ过度表达和GRα功能受损.
研究的目的:
- 审查慢性系统性葡萄糖皮质激素 (GC) 在严重喘中使用的挑战.
- 评估生物疗法在减少GC负担中的作用.
- 为了强调精准医学和类固醇管理的重要性.
主要方法:
- 关于严重喘管理策略的文献综述.
- 对生物疗法临床试验数据的分析.
- 讨论GC耐药性和毒性的分子机制.
主要成果:
- 针对IgE,IL-5,IL-4Rα和TSLP的生物疗法显示出显著的口服皮质类固醇 (OCS) 节约作用.
- 这些疗法使得在依赖类固醇的喘患者中减少或停止OCS剂量.
- 生物医学与精准医学保持一致,提供表型特定的治疗.
结论:
- 在严重喘管理中,尽量减少慢性GC使用至关重要.
- 生物疗法代表了减少GC暴露和改善长期结果的变革性方法.
- 未来的方向包括生物标记驱动的选择和增强的类固醇管理协议.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
420
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
420
COPD: Management Using Bronchodilators and Corticosteroids
709
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
709
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K


